Valuation: Terumo Corporation

Market Cap 3,215B 19.83B 17.34B 16B 14.7B 27.86B 1,908B 28.34B 191B 74.93B 933B 74.48B 72.85B P/E 2027 *
19.3x
P/E 2028 * 17.3x
Enterprise Value 3,291B 20.3B 17.75B 16.37B 15.05B 28.52B 1,953B 29B 195B 76.69B 955B 76.23B 74.56B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.46x
Free-Float
97.07%
Yield 2027 *
1.64%
Yield 2028 * 1.83%
1 day+1.26%
1 week-0.92%
Current month-1.21%
1 month-0.59%
3 months+0.87%
6 months+0.23%
Current year-2.78%
1 week 2,168.5
Extreme 2168.5
2,266.5
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%-0.92%-9.44%+0.34% 19.83B
+0.35%-6.21%-32.11%-17.29% 155B
+1.48%-1.88%-9.81%-8.19% 103B
-1.89%-4.20%+0.65%+54.93% 57.7B
-1.11%+1.09%+37.83%+53.63% 52.27B
+2.81%+2.87%-13.14%-40.29% 42.68B
+2.02%-2.13% - - 33.35B
-1.88%-1.80%-14.21%-47.04% 28.06B
+0.38%+1.50%+62.41%-6.78% 25.36B
-0.48%+4.68%-3.27%-17.94% 21.03B
Average +0.28%-0.22%+2.10%-3.18% 53.88B
Weighted average by Cap. +0.35%-1.81%-7.16%-2.26%

Financials

2027 *2028 *
Net sales 1,236B 7.63B 6.67B 6.15B 5.66B 10.72B 734B 10.9B 73.45B 28.82B 359B 28.65B 28.02B 1,315B 8.11B 7.09B 6.54B 6.01B 11.4B 781B 11.59B 78.12B 30.65B 382B 30.47B 29.8B
Net income 166B 1.02B 893M 824M 757M 1.43B 98.25B 1.46B 9.83B 3.86B 48.02B 3.83B 3.75B 185B 1.14B 999M 921M 847M 1.6B 110B 1.63B 11B 4.32B 53.73B 4.29B 4.2B
Net Debt 75.69B 467M 408M 377M 346M 656M 44.93B 667M 4.5B 1.76B 21.96B 1.75B 1.72B 14.29B 88.16M 77.07M 71.1M 65.36M 124M 8.48B 126M 849M 333M 4.15B 331M 324M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
16/07/26 ¥2,207.00 +1.26% 3,874,900
15/07/26 ¥2,179.50 -2.40% 3,917,600
14/07/26 ¥2,233.00 +0.88% 3,221,300
13/07/26 ¥2,213.50 +1.12% 3,004,900
10/07/26 ¥2,189.00 -1.73% 4,601,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,179.50JPY
Average target price
2,961.54JPY
Spread / Average Target
+35.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock